Monitoring agency report: no deviation in use of warrant issue proceeds
Transchem Ltd has shared the Monitoring Agency Report from Acuite Ratings & Research Ltd for the quarter ended September 30, 2026, on how money raised through a preferential issue of warrants is being used.
By ScoutQuest · · 2 min read
- Issue size
- INR 461.25 Cr — 6,15,00,000 warrants at INR 75.00 each
- Amount raised so far
- INR 115.31 Cr, or 25.00% of the issue size
- Balance receivable
- INR 345.94 Cr (75%), receivable on warrant conversion within 18 months, by December 2027
Transchem Ltd has disclosed the Monitoring Agency Report prepared by Acuite Ratings & Research Ltd for the quarter ended September 30, 2026. The report relates to the money raised through a preferential issue of fully convertible equity share warrants.
What a monitoring agency does
A monitoring agency is an independent agency appointed to check whether the money a company raises from investors is actually used for the purposes stated at the time of the issue. It reports periodically, and the company places that report before its Audit Committee and Board.
What the agency reported
- Deviation from the objects: No deviation is observed.
- Range of deviation: Not Applicable.
- Any other material fact to be highlighted: None.
- The report was reviewed by the Audit Committee and taken on record by the Board of Directors at their respective meetings held on November 04, 2026.
The issue in numbers
- Type of issue: preferential issue of fully convertible equity share warrants.
- Units issued: 6,15,00,000 warrants at an offer price of INR 75.00 each.
- Issue size: INR 461.25 Cr.
- Amount raised: INR 115.31 Cr, which is 25.00% of the issue size.
- Balance receivable: 75% of the issue size, that is INR 345.94 Cr, receivable upon exercise of the warrant conversion option within 18 months from the allotment date, by December 2027.
The checklist the agency covered
- Whether utilisation is as per the disclosures in the Offer Document: Yes; utilisation in the respective objects is as per the company's disclosures.
- Whether shareholder approval was obtained for material deviations from the expenditure disclosed in the Offer Document: Not Applicable; no material deviation observed.
- Whether the means of finance for the disclosed objects has changed: No; no change observed.
- Whether any major deviation was observed over earlier monitoring agency reports: Not Applicable; no deviation reported in the preceding reporting periods.
- Whether all government or statutory approvals related to the objects have been obtained: Yes; no such approval is required for the objects.
- Whether arrangements for technical assistance or collaboration are in operation: No; no such arrangement is required with reference to the object.
- Whether any favourable or unfavourable event was observed affecting the viability of the objects: No on both counts.
- Whether any other relevant information exists that may materially affect investor decisions: No such information was evident.
How to read the structure of the money
The issue is structured so that 25.00% of the issue size, or INR 115.31 Cr, has been raised, and the remaining 75%, or INR 345.94 Cr, is payable when the conversion option on the warrants is exercised within the stated 18-month window, with December 2027 indicated as the reference point.
What this update is
This is a periodic update on the tracking of issue proceeds. The agency's finding is that the money used so far matches the stated objects, and the disclosures around the issue remain unchanged.
Also from Transchem
Board approved unaudited standalone and consolidated results for the quarter ended September 30, 2026
4 Nov 2026
Board Meeting Scheduled on November 04, 2026 to Approve Un-Audited Results
27 Oct 2026
More numbers
- Warrants issued6,15,00,000
- Offer price per warrant75.00
- Issue sizeINR 461.25 Cr.
- Amount raised115.31
- Share of issue size raised25.00
- Balance receivable on conversion75%
- Balance receivable amountINR 345.94 Cr.
- Conversion window from allotment18 months
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.